News and price dashboard

Veea down hard on a partnership announcement

VEEA is the worst mover on the list, down 13.6%, and the only news behind it is a positive one: a one-year deal announced October 6 with La Estadia, a community of 220 residential properties, to put Veea's SecureConnect platform and its Veea Vision edge-AI video analytics into the community's network. The GuruFocus piece spends most of its length on the balance sheet rather than the deal. Market cap is $18 million, price-to-sales is 28.3 against a historical median near 109x, the company is unprofitable so P/E doesn't apply, and the GF Score is 4 out of 100 with financial strength at 1/10 and an Altman Z-Score of -11.61. No guru holdings, no insider buying or selling in the past twelve months. The article does not explain today's drop.

Iovance 8-K

IOVA is down 8.4% with an 8-K filed under Item 8.01 (Other Events). That's headline only, so the contents aren't known from here. Given the size of the move against a filing that could say anything, this is the one worth opening yourself.

AST SpaceMobile up 8% despite a cut estimate

ASTS rose 8.0%, and the news flow is mixed. William Blair kept a Market Perform rating but cut its 2027 revenue estimate to $459 million from $752 million, blaming a slower launch cadence for the BlueBird II satellites and shipment delays. The firm now assumes fewer than 20 satellites in orbit by end-2026, against the company's own start-of-year expectation of at least 45. BlueBirds 14, 15 and 16 have shipped to Cape Canaveral, so another launch could come in the next few months, and Abel Avellan says BlueBird 11 is fully deployed with all 13 satellites performing. The offsetting item is the first completed integration test with TELUS, linking TELUS's wireless network to the satellite constellation for direct-to-phone data, voice and text, with service to TELUS customers expected within a year. Context from the same articles: Q2 showed adjusted EPS of -$0.77 against -$0.26 expected and revenue of $31.52 million versus $35.18 million expected, though sales more than doubled sequentially. B. Riley cut to Neutral with a $65 target from $85, Berenberg started at Buy with $92, Cantor raised to $90 at Overweight. Insiders have sold $451.6 million over twelve months against $0.8 million bought. ASTS also appeared on a GuruFocus list of communication services growth names with an A+ growth grade, at 155x sales versus a 62x historical median.

Astera Labs and the S&P 500 inclusion trade

ALAB is up 7.6% and there's an actual stated reason: traders positioning for inclusion in the S&P 500 at the next quarterly rebalance. Market cap near $47.6 billion clears the $22.7 billion minimum, passive funds are roughly 30% of assets tracking the index, and analysts have named it a top candidate. Fubon also initiated at Buy with a $500 target. The fundamentals behind it: Q2 revenue of $392.4 million, more than double a year ago and ahead of the $360.7 million expected, adjusted EPS of $0.80 versus $0.69, and Q3 guidance of $540-560 million at 72% gross margin and 43% operating margin. Scorpio X AI fabric switches are in volume production ahead of schedule and PCIe 6.0 products have passed 50% of quarterly revenue. The stock had been more than 36% off its $499.48 record before this rally. Two counterweights in the same batch: ETFs were net sellers of $16.4 million on Friday, a third straight day of outflows after $13.4 million Thursday and $17.7 million Wednesday, led by SOXX at $12.6 million and QQQ at $4.3 million. And a WarrenAI ranking put Credo first ahead of Astera and Marvell, flagging Astera's InvestingPro Fair Value at $230.05, implying 40.6% downside, against 98.5% revenue growth and 75.1% gross margin. A TradingView post argued against chasing the $400 gap and favoured a retest near $378.

Credo alongside Astera in the same networking ranking

CRDO is up 3.9% and sits at the top of that same WarrenAI list, with 165.1% revenue growth, 67.1% gross margin, debt to capital of 0.1%, Fair Value of $232.44 and an analyst target of $279.09. The piece noted optical DSPs, silicon photonics and ZeroFlap Optics were each expected to top $100 million of revenue in fiscal 2027. Separately and headline-only, Stifel lowered its Credo target to $310 and chief legal officer James Laufman sold 5,000 shares.

Nebius up 7.4% on a technical break

NBIS rose 7.4%, with GuruFocus describing a roughly 9% jump to around $253.25 that cleared the $250 resistance level on about 11.55 million shares by midday, with MACD positive and RSI near 70. It trades at 51.84x sales versus a 6.98x historical median, GF Score 52 with momentum at 9/10 and valuation at 2/10. Two days earlier the stock was down 3% to $235.00 when it announced the acquisition of inference optimizer Inferize, folded into Nebius Token Factory, with no price disclosed and no utilization target or savings figure given. That same piece noted Michael Burry had added to a bearish position ahead of an expected semiconductor downturn. On insiders, executives sold $19.07 million of shares at $234.16 to cover taxes on vested RSUs: Volozh about $8.85 million, Korolenko about $6.81 million, Shtan about $3.41 million, all filed as automatic rather than discretionary, with large positions retained. Twelve-month insider selling totals roughly $199 million. Quarterly revenue was $582.3 million, up 454% year over year, and the company signed a 12-year deal for 50 megawatts of AI data-centre capacity. Two TradingView posts take opposite sides, one looking for a retrace not below $205, another short on weak volume behind the breakout.

Butterfly Network hit a 52-week high and then fell

BFLY is down 7.2% despite an Investing.com piece noting it touched a 52-week high at $10.05, trading $10.15 for a $2.66 billion market cap and up 292.2% over a year. Q2 showed adjusted EPS of -$0.01 against -$0.04 expected but revenue of $15.72 million versus $29.15 million expected, with the company pointing to record margins and higher US sales and raising full-year guidance. Evercore ISI started at Outperform with a $15 target, Needham at Buy with $10. Separately there's an 8-K under Item 5.02, covering a departure or appointment of officers or directors, which is headline only here and is the likelier thing behind today's drop.

AMC financing 8-K

AMC is up 6.1% on an 8-K covering entry into a material definitive agreement, termination of another, and creation of a direct financial obligation, plus Reg FD disclosure. Headline only, but the item list points to a refinancing of some kind.

Broadcom rally with several threads

AVGO is up 3.7% and there are a dozen headlines on it, none read in full. The ones with actual content in the headline: the FT reporting Wall Street testing lender appetite for a $60 billion Broadcom-Anthropic deal, Cathie Wood buying $13 million of stock, net ETF buying of $373.5 million on October 2, UBS adjusting its TPU model on v10 design changes, and a GuruFocus piece saying power bottlenecks leave forecasts intact. A DCF item puts intrinsic value at $225 against a $355 price.

Revolution Medicines and the biotech selloff

RVMD is down 3.8%, and an IBD headline frames it as part of a broader biotech pullback hitting recent winners including Moderna and Vaxcyte. The company separately began a phase 3 pancreatic cancer trial. Both headline only.

Smaller analyst and insider items

Kodiak Gas Services is up 4.4%, with Barclays lowering its target to $67 and a Form 144 filed. Generac is up 3.9% with Cantor Fitzgerald cutting its target to $297, described in the headline as a valuation reset. On Holding is up 4.0% on a GuruFocus GF Score note. Xenon hit a 52-week low and is down 2.7%, while Guggenheim assumed coverage at Buy with a $73 target. SanDisk is down 2.6% and testing support near $1,670, with a separate Outperform reiteration at a $2,050 target. NetApp is up 2.1% on a TD Cowen target raise to $250, with CEO George Kurian selling 10,000 shares and director Gerald Held 5,757. Vicor is down 2.1% with the CEO selling $6.3 million and a VP selling 3,072 shares. Pagaya is down 1.9% after TD Cowen cut to $25, alongside a closed $600 million AAA-rated ABS deal.

Netflix, Oracle and the rest, quiet

The remaining names moved little. Netflix is up 1.8% with a cluster of pre-earnings notes: Goldman lowered its target to $90 on engagement concerns, TD Cowen reiterated at $100, StoneX kept Hold. Oracle is up 1.6% on a mix of a health data breach affecting nearly 20 million people, a $10 million donation to the Nashville Symphony, and insider buying of about $3.5 million. Amphenol hit an all-time high and is up 1.6%, with Goldman raising to $116. TSMC is down 0.7% despite a heavy news flow around Terafab talks with Musk that Musk confirmed without a deal, plus a Barclays target raise to $665. SpaceX is up only 0.5% across roughly thirty headlines covering a proposed 32-mile Florida gas pipeline for Starship, a Goldman target hike and Morgan Stanley's Overweight. Apple is flat at +0.2% under a long list of ETF flow items and insider sales including Tim Cook's $63.8 million. Everything else here, Joby, Vertiv, Marathon, Costco, TeraWulf, Si-Bone, Aflac, is routine filings and broker notes with no meaningful move.

Brazil election drives BBD and ITUB

The two biggest moves on the list are both Brazilian banks, and they share one cause. Banco Bradesco is up 18.8% and Itaú Unibanco up 15.5% after Brazil's October 4 first-round presidential vote, where Liberal Party senator Flávio Bolsonaro took roughly 47% of valid votes against Lula's roughly 45%. Neither cleared 50%, so it goes to a runoff on October 25. Pre-election polling had generally shown Lula slightly ahead, so the result read as a surprise to investors who associate a Bolsonaro presidency with more market-friendly fiscal and regulatory policy. Investing.com puts Bradesco's pre-open gain at 13.6% to $3.59 and Itaú's at 10.7% to $9.51, against a 52-week high of $9.60. Two secondary points on Bradesco: today is the ex-dividend date for BBDO, and several Bradesco executive officers each bought roughly $1.0m to $1.4m of stock in mid-September. On Itaú, the same outlet notes JPMorgan had already raised its target to $10 from $9 with an Overweight rating, and that Q2 recurring net income was BRL 12.4bn, up 7.8% year on year, with return on equity of 24.3%. Both articles stress the US indices were flat that session, so the move was Brazil-specific, and both note the extra 25% US tariff on a range of Brazilian goods in place since July 2026 as part of why these assets swing hard on politics. One item tagged ITUB is actually about XP Inc, upgraded to Outperform by Itaú BBA with a $27 target while the stock traded at $28.15; GuruFocus flags $2.4m of XP insider selling over three months.

SpaceX up 7.6% on Morgan Stanley and AI pivot

SPCX is up 7.6%, closing at $171.09, its highest since mid-June, and it dominates the list by volume of coverage. The immediate news item is a proposal to Florida's Public Service Commission for a 32.4-mile natural gas pipeline in Brevard County to supply methane for Starship launches from Cape Canaveral, connecting to Florida Gas Transmission and replacing trucked LNG. SpaceX would still need liquefaction infrastructure on site. The larger driver in the coverage is Morgan Stanley: Adam Jonas reiterated Overweight with a $300 target, calling the stock cheap relative to mega-cap AI peers and pointing to AI products, Starship progress and new cloud contracts. GuruFocus says the move added about $30.6bn to Musk's net worth, taking it back above $1 trillion, helped also by Tesla's third-quarter sales beat. Wells Fargo is cited saying engineers are being moved from launch and connectivity into orbital data centres, with an AI satellite demonstration planned for Q2 2027, which depends on Starship reaching a faster cadence. Counterweights in the same material: GuruFocus gives SPCX a GF Score of 15/100, a P/S of 179.72 against a historical median near 103.6, trailing revenue of $12.51bn up 33.2% with a -38.5% net margin, no insider buying and roughly $53.7m of insider selling over twelve months. ETFs were net sellers of $41.7m on October 2, led by QQQ at $48.6m, breaking three days of inflows. Headline-only items add that Musk is renaming the AI unit to SpaceXSI, echoing Trump's "super intelligence" phrasing, and that a Starship test flight and Q3 results are expected late October.

SI-BONE insider sale alongside a 9.6% gain

SIBN rose 9.6% to close at $19.81. The news attached to it is a director sale, not a company event: Jeffrey W. Dunn sold 20,000 shares on October 1 at a weighted average $18.47 for $369,400, under a 10b5-1 plan set up in May 2025, and on the same day exercised 20,000 options at $4.68. He directly holds 16,057 shares afterwards, with 81,073 held through a family trust. For background the article notes Q2 revenue up 15.2% to $56m and an adjusted loss of $0.09 versus a $0.16 expected loss, with guidance raised, and Canaccord keeping Buy at $27. Worth noting the Yahoo chart item flags the day's gain came on volume roughly in line with average, and pre-market it was quoted down 3.03%.

Semis, analyst notes and the rest

Nothing else here moved more than about 5%, and most of it is routine. TSM is up 2.8% on a stack of headline-only items: Terafab collaboration chatter, a Goldman Sachs target increase, and an Arizona expansion figure of $265bn. Broadcom is up 2.1%, with headlines on a reported $60bn Broadcom-Anthropic financing being tested with lenders and a UBS adjustment to its TPU model. Marathon Petroleum, up 2.6%, hit an all-time high at $431.23 per one headline. On the downside, TeraWulf is off 4.5% despite a headline about expanding Muskie data campus power capacity to 1 GW, and Nebius is down 4.2% with headlines citing roughly $19m of executive stock sales and a Burry short. Joby is down 2.9% on a cluster of small routine officer sales. Credo slipped 2.8% with Stifel lowering its target to $310, Generac saw Cantor Fitzgerald cut to $297, Kodiak Gas had Barclays cut to $67, Incyte had Stifel raise to $157, and BMO started Vertiv at Outperform. Apple, essentially flat, carries a long tail of ETF-flow items and Form 4 filings including a $63.8m sale by Tim Cook; Oracle is flat too, with headlines on a health-unit breach said to affect close to 20 million people. None of that cluster has substance behind it beyond the headline.

Veea up 69.7% on a financing filing

The biggest move on the list is Veea, up 69.7%, and all that sits behind it here is an 8-K covering entry into a material definitive agreement and the creation of a direct financial obligation. That's a headline-only item, so there's no detail on terms. If you hold it, this is the one worth opening the filing yourself.

Brazil banks surge on election first round

Bradesco is up 18.6% and Itaú up 15.4%, and both are the same story. Brazil's first-round presidential vote on October 4 gave Liberal Party senator Flávio Bolsonaro roughly 47% of valid votes against Lula's roughly 45%, with neither clearing 50%, so the race goes to a runoff on October 25. Pre-election polling had generally shown Lula slightly ahead, so the result was a surprise and investors read it as friendlier to market-oriented fiscal and regulatory policy. Bradesco rose 13.6% in pre-open to $3.59, against a 52-week high of $3.80, helped additionally by today being the ex-dividend date for BBDO and by insider buying in mid-September, with several executive officers each putting roughly $1.0m to $1.4m into the shares. Itaú traded up 10.7% pre-open to $9.51 versus a $9.60 52-week high; the article also notes JPMorgan had already raised its target to $10 from $9 at Overweight, and that Itaú's Q2 recurring net income was BRL 12.4bn, up 7.8% year on year, with a 24.3% return on equity. Both pieces stress the US market gave no help at all, with the major indices roughly flat pre-market, so this was entirely a Brazil political repricing. Worth noting the Itaú piece also mentions the extra 25% US tariff on a range of Brazilian goods in place since July. A separate headline flags ILF among Monday's ETF movers, same driver.

SI-BONE up 9.3% with no stated cause

SI-BONE closed at $19.81, up 9.57% on the day per the Yahoo page, on volume of 622,007 against an average of 553,132. The page carries no news item explaining the move. The only analyst action shown is dated 4 August, UBS maintaining Buy and raising its target to $25 from $24, with the average estimate at $25.22. The stock's 52-week range is $11.48 to $21.89 and it's up about 51% over six months. Q2 revenue was $56.01m with a $4.09m loss, and the next earnings date is 9 November.

SpaceX up 7.6% on Morgan Stanley plus the AI rebrand

SpaceX closed at $171.13, up 7.66%, the heaviest-covered name on the list. The trigger was Adam Jonas at Morgan Stanley reiterating Overweight with a $300 target in a note titled "cheap and getting cheaper," implying about 89% upside from the roughly $159 level cited that morning. His argument is growth-adjusted rather than absolute: about 30x 2028 EV/EBIT against roughly 16x for mega-cap AI peers, but around 0.3x EV/EBIT/growth versus a 0.5x median, with the AI unit priced at roughly $32 a share on his split. He also said client interest has gone "really, really quiet" and that in a room of 40 clients no one raised a hand as an owner. Street consensus target is $235.10. The second driver was Musk confirming over the weekend that the AI unit will be renamed from SpaceXAI to SpaceXSI, matching Trump's executive order directing the government to use "superintelligence" instead of "artificial intelligence." That AI segment brought in $2.56bn last quarter versus $962m from Space. Macro helped too: September payrolls came in at just 29,000 with unemployment at 4.2%, which cut expectations for a near-term Fed hike and favoured high-multiple growth names.

SpaceX fundamentals, pipeline and what's next

Against that, the Investing.com breakdown lays out the other side. Q2 revenue was $7.81bn, up from $4.69bn in Q1 and ahead of the $6.81bn estimate, with EBITDA of $2.78bn but EPS of -$0.09. Levered free cash flow was -$32.52bn and total debt $39.71bn as of 30 June, and Morgan Stanley's own model assumes roughly $80bn a year of net debt issuance. GuruFocus puts the price-to-sales ratio somewhere between 167x and 176x depending on the note, against a 103.6x historical median, and gives a GF Score of 15 out of 100, weak on profitability and growth, with financial strength at 6 out of 10. Insiders have sold about $53.7m over the past year with no buying, while 16 tracked gurus all added. Technicals are stretched after a 16% week, with RSI at 67.9 and the weekly stochastic at 93.5; the 20-day SMA sits at 151.19. Separately, Walter Bloomberg reported SpaceX is seeking approval for a 32.4-mile natural gas pipeline in Florida to supply methane for Starship launches from Cape Canaveral, connecting to Florida Gas Transmission and replacing trucked LNG, though liquefaction infrastructure would still be needed. IBD reports Monday's SDA launch was postponed and will be reattempted Tuesday. Dates ahead: Starship Flight 15 late October or early November, with Jonas calling a ship catch potentially the biggest positive catalyst since the IPO, and Q3 earnings tentatively 5 November. A TradingView post from TheTraderPhil flags $170 and $220 as levels, which is one trader's chart view, not research.

Smaller movers with thin backing

Butterfly Network is up 5.1%, with an 8-K on an officer departure or appointment and a headline referring to a 22% surge on an analyst initiation, though no detail on who. Beam is up 4.8% on nothing but two TradingView chart posts. TeraWulf is down 4.4% despite a headline saying it expanded power capacity at its Muskie data campus to 1 GW, plus an 8-K and a Form 4. Nebius is down 4.2%, with a headline tying the fall to a Michael Burry short against an Inferize bet, and it also appears on a BofA list of software stocks to sell over AI agent risk. CRSP is up 3.6% on a chart post only, ALAB up 3.5% on an options volatility note, and Forgent Power Solutions is down 3.5% even as Bernstein initiated coverage at Outperform.

TSMC, Marathon and the rest

TSMC is up 2.8%, with IBD making it stock of the day on talk it may take a role in Musk's planned Terafab chip factory, backed by two GuruFocus headlines on the same discussions. Marathon Petroleum is up 2.6% and hit an all-time high at $431.23, with headlines noting it gained nearly 48% in Q3 as the energy sector rallied on Middle East tensions. Broadcom is up 2.2%, with a UBS note adjusting its TPU model for v10 design changes and two Investing.com pieces asking why the stock was volatile. Everything below that is essentially flat. The remaining items are routine: Form 4s at Vicor, SanDisk, Incyte and Stagwell, BMO initiating Vertiv at Outperform, Stifel raising Incyte's target to $157, Cantor cutting Generac to $297, Barclays cutting KGS to $67, Stifel cutting Credo to $310, TD Cowen keeping Netflix at $100 alongside a Disney licensing deal that sends titles including Percy Jackson and Ice Age to Netflix, William Blair trimming AST SpaceMobile revenue estimates on launch delays, and a long run of ETF flow and DCF-valuation posts on Apple and Oracle that carry no company news.

Celularity up 16% with no news attached

CELU was the biggest mover on the list, up 15.9% to $1.60 from a $1.38 close, trading a day range of $1.36 to $1.63. The only item behind it is a Yahoo quote page, so there is no stated reason for the move. Worth noting the volume picture: the chart alert flags the move as 1.8 times the stock's own ATR20 but on roughly 0.4 times the 20-day average volume, and the quote page shows 221,844 shares against a 3.9M average. The stock is still down 97.8% over five years, with a 52-week range of $0.56 to $2.55 and a market cap near $52M.

Planet Labs higher while insiders keep selling

PL rose 8.4% to $17.50 on 14.9M shares against an 8.8M average, again with no catalyst named in any of the items. What the GuruFocus pieces do give you is insider data: director Ita Brennan sold 11,500 shares on October 1 at around $16.30, leaving her with 250,373 shares, and she has sold 59,500 shares over the past year with no purchases. Company-wide there have been 22 insider sells against one buy in twelve months, totalling $52.6M. GuruFocus puts its own GF Value at $5.63 against the $17.50 price, calls that 210.8% overvalued, and scores the stock 60/100 with profitability at 2/10 and growth at 7/10. Seven gurus hold it, four adding and three trimming. One caution on the list itself: the 8-K tagged to PL is for Planet Green Holdings Corp, a different company.

Forgent Power Solutions and the Bernstein initiation

FPS gained 8.1%, and this one has a clear driver. Bernstein SocGen initiated coverage at Outperform with a $48 target, roughly 29% above the prior close of $37.33. Analyst Chad Dillard's case: FPS is a pure-play electrical OEM with about 80% of revenue from data centers and the grid, and he models a 70% EPS compound annual growth rate through 2030 versus consensus near 60%, with earnings revisions as the mechanism that closes the valuation gap to peers. The modular data centre shift, which he expects to go from 40% to 60% of the market by 2030, lifts FPS content per megawatt by 55% to $2.8M as it sells integrated systems instead of components. He also points to lead times 30% to 50% below industry average, a 7% share among non-hyperscalers against 4% overall share, a first hyperscaler win, and EBITDA margin expanding 500 basis points to 28% by 2030. The stock touched $40.28 intraday, still well below its $66 52-week high; it IPO'd in February 2026. GuruFocus notes a trailing P/E of 138.77x, a market cap around $11.36bn, and a GF Score of 20/100. A TradingView post separately flags a 50-day SMA cross and a cup-and-handle at resistance, with a $40.50 trigger and $52.35 target, which is one trader's chart view, not research.

SpaceX rebrands AI unit, Morgan Stanley reiterates

SPCX was up 7.4%. The news item is a branding one: Musk confirmed on X that SpaceXAI will be renamed SpaceXSI, following Trump's push, made in a UN General Assembly speech last month, for documents to use "super intelligence" instead of "artificial intelligence." No timetable was given, the X account had not changed at publication, and Musk gave no change to products, strategy or investment plans, so by the articles' own framing it is branding only for now. Alongside that, Morgan Stanley's Adam Jonas reiterated Overweight with a $300 target, arguing the stock trades roughly 40% below mega-cap AI peers on a growth-adjusted basis and flagging upcoming Starship flights, Q3 earnings, Grok releases and further neocloud deals as catalysts, with a successful Starship catch potentially the biggest since the IPO. On flows, 22 ETFs added SPCX on October 1 against 10 sellers, a net $46.8M, extending a three-day run after $111.2M on September 29 and $64.4M on September 30; QQQ led with $36.4M and the Indxx Aerospace & Defense ETF added $6.9M as part of a day in which it increased all 39 of its positions. Fundamentals cited: trailing revenue $12.51bn, up 33.2%, gross margin 51.2%, net margin -38.5%, P/S of 166.96 against a 103.61 median, market cap $2.16tn, GF Score 15/100, and $53.7M of insider selling over twelve months with no buys while 16 gurus added and none trimmed. The remaining SPCX items are headline-only and cover Starlink V3 deployments, in-flight streaming and broad market commentary.

NetApp, Butterfly, Rocket Lab, Generac

Four mid-sized movers, all headline-only. NTAP rose 5.2% to what one headline calls an all-time high, with Loop Capital raising its target to $260 and GuruFocus flagging a GF Score of 88 alongside an overvalued GF Value read. BFLY was up 4.9%, with an 8-K covering an officer departure and appointment, and a separate TradingView headline referencing a 22% surge on an analyst initiation. RKLB also gained 4.9%, with headlines citing a record 20-launch deal and Cathie Wood buying $16M of the stock while selling Palantir. GNRC rose 4.3% and crossed above its 200-day moving average, while Cantor Fitzgerald cut its price target citing a valuation reset.

Chips, software and energy names in the 3% band

AVGO added 3.3%, with headlines pointing to a $60bn debt package to fund AI infrastructure and an AI chip guide of $21.7bn. ORCL rose 3.1% on a heavy but headline-only item flow: an insider purchase of nearly $3.5M, Citizens maintaining a $285 target, a power subscription at the Point Beach nuclear plant, and a $10M donation to the Nashville Symphony. TSM gained 3.0%, with headlines on a possible Terafab collaboration with Musk and a High-NA roadmap targeting 2030. WULF was up 3.9% with an 8-K and a Form 4, SNDK fell 3.8% with its chief legal officer selling about $1M of stock, and BBD rose 4.0%.

Smaller moves and the quiet tail

VRT rose 2.5% on a BMO initiation at Outperform tied to data centre growth, while ASTS also gained 2.5% despite a B. Riley downgrade with the target cut to $65. INCY slipped 1.6% as Stifel raised its target on pipeline potential. Beyond that, the remainder of the list is routine: a large block of ETF flow and GF Value notes attached to AAPL, which moved 1.0%, plus Form 4s, DCF commentary and chart posts on COST, NFLX, MPC, TEVA, JOBY, RVMD, BEAM and CRSP, none of which moved more than about 1%.

CELU up 16% on almost no volume

Celularity led the watchlist, up 15.9% to close at $1.60. Nothing in either item explains why. The Yahoo page is just the quote itself, and the Nasdaq earnings page for the June 2026 quarter is empty, with no date, no estimate, no reported figures. The one detail worth noting is the volume: 221,844 shares against a 20-day average of roughly 3.9 million, so this was a 16% move on about a twentieth of normal turnover in a $52 million market cap name. The stock is up 44% year to date and down 21.6% over twelve months, with a 52-week range of $0.56 to $2.55.

Planet Labs, launch plus insider selling

Planet Labs rose 8.4% to $17.50 on 14.9 million shares against an 8.8 million average. The event behind it was Wednesday's launch: on October 1 Planet put 20 satellites up on SpaceX's Transporter-18 rideshare from Vandenberg, its 40th successful launch. The payload included Tanager-2, its hyperspectral satellite, 18 SuperDoves, and a demonstration satellite for Google's Project Suncatcher, which is testing Google Tensor Processing Units in orbit with the aim of running machine learning computation in space. Cutting the other way, GuruFocus flagged that director Ita Brennan sold 11,500 shares on October 1 at around $16.30, leaving her with 250,373, and that insiders have sold $52.6 million over the past twelve months across 22 sells against a single buy. GuruFocus puts its GF Value at $5.63 versus the $17.50 price, a P/S of 14.27 against a historical median of 4.72, and a GF Score of 60 to 62 out of 100, with growth and momentum at 7/10 and profitability at 2/10. Trailing revenue is $378m with a net loss of $360m. One item in the list tagged to PL is an 8-K from Planet Green Holdings Corp, a different company, so ignore it.

Forgent Power on Bernstein initiation

Forgent Power Solutions gained 8.1%, driven entirely by Bernstein SocGen initiating coverage at Outperform with a $48 target against a prior close of $37.33, roughly 29% above. Chad Dillard's argument is that FPS is a pure-play electrical OEM with about 80% of revenue from data centers and the grid, and that the street is underrating three things: content per megawatt rising as modular data center construction goes from 40% of the market to 60% by 2030, which lifts FPS's content opportunity 55% to $2.8 million per megawatt as it sells integrated systems rather than discrete components; share gains, with FPS at roughly 7% among non-hyperscalers versus 4% overall plus a first hyperscaler win; and margin expansion of 500 basis points to a 28% EBITDA margin by 2030 on utilization, SG&A leverage and modular mix. He models a 70% EPS CAGR through 2030 against roughly 60% consensus. Lead times are said to run 30% to 50% below industry average. The stock traded as high as $40.28 and remains well under its $66 52-week high, having IPO'd in February 2026. Context from the same articles: revenue grew 88.5% over the last twelve months, backlog was up 53% quarter on quarter on record orders, FY27 revenue guidance came in about 20% above consensus, and existing coverage includes TD Cowen at $76 Buy, KeyBanc at $60 Overweight and Wells Fargo at Equal Weight $44. GuruFocus takes the opposite view on valuation, citing a 138.77x trailing P/E and a GF Score of 20 out of 100.

SpaceX renames itself, Starlink chatter

SPCX closed up 7.4% at $158.96 on 119.9 million shares, one of the most active names on the US tape. The concrete news is a rebrand: Musk posted "SpaceX is a super intelligence company" and separately confirmed the company will change its name to SpaceXSI, following Trump's September 29 executive order directing federal agencies to use "Super Intelligence" and "SI" in place of "Artificial Intelligence" and "AI". No timing was given. Alongside that, Musk amplified a post about a passenger streaming five live college football games at once over Starlink on a United flight, with United now carrying Starlink on 500-plus aircraft. A TradingView note said support held and attributed momentum to newly announced government contracts. The headline-only items around it point the same direction: Starship deploying Starlink V3 satellites, the Alphabet Project Suncatcher prototype riding Transporter-18, elevated options activity, IBD flagging a buy signal, and pieces asking how large Starlink's residential broadband business can get and whether SpaceX would target airlines and maritime before big wireless. One headline, from GuruFocus, argues its 2027 profit is already expensive. A number of unrelated 13F items from Millennium and TPG are mis-tagged to SPCX.

NetApp, Rocket Lab and the rest of the gainers

Below that, headline-only. NetApp was up 5.2%, with headlines on an all-time high, a Loop Capital target raise to $260, and NetApp storage aimed at AI migration alongside Oracle. Rocket Lab rose 4.9%, with headlines citing a record 20-launch deal and Cathie Wood buying $16 million of it while selling Palantir; one older Investing.com headline references a 43% plunge, so check dates there. Butterfly Network has a headline claiming a 22% surge on an analyst initiation. Generac was up 4.3% and crossed above its 200-day. TeraWulf rose 3.9%, Pagaya 3.1%.

Broadcom and Oracle clusters

Broadcom gained 3.3% against a thick run of headlines, the recurring one being that it is lining up a $60 billion debt package to fund AI chips, reportedly for Anthropic per Bloomberg, plus a $21.7 billion AI chip guide and a UBS Buy reiteration. Oracle was up 3.1%, with Citizens reiterating Outperform at $285, a director purchase by Stephen Rusckowski of $3.48 million, a power subscription commitment at the Point Beach nuclear plant, and a DOCOMO database licence reduction of 43%. TSMC rose 3.0% on headlines about a possible Terafab partnership and a High-NA roadmap to 2030.

Decliners and the quiet end

On the downside, SanDisk fell 3.8%, with headlines on chief legal officer Bernard Shek selling 600 shares worth about $1 million. Veea was down 4.0% alongside an 8-K covering a material agreement and a new financial obligation. BigBear.ai fell 3.3%, BeyondSpring 3.2% with an 8-K on a delisting or continued-listing notice. AST SpaceMobile was up 2.5% despite a B. Riley downgrade with the target cut to $65 on pricing concerns. Netflix slipped 1.2% on a Disney licensing deal bringing titles including Ice Age and Percy Jackson to the platform, plus a Spain partnership with Filmin. Apple edged up 1.0% with a large volume of low-substance ETF flow and commentary headlines, the only specific items being new macOS privacy controls flagging AI requests for Mac data after complaints about Meta's Muse, an iPhone 18 Pro Max replacement programme for connectivity issues, and an insider sale by Jennifer Newstead. Everything else on the list, Costco, Teva, Marathon, Aflac, Joby, Take-Two, Iovance, moved under 1% and the items attached are routine filings, 13F notes and ETF flow reports.

Celularity up 16% with no news behind it

CELU was the biggest mover on the list, up 15.9% to close at $1.60, and nothing in the material explains why. The only two items read in full were a Yahoo quote page and a Nasdaq earnings page that returns no data at all for the name. Worth noting from the quote page: volume was only 220,034 shares against a 3.9 million average, so this was a thin tape, not a crowded one. Market cap is $51.9 million, the 52-week range is $0.56 to $2.55, and trailing EPS is -$3.59 on $18.97 million of revenue. There is no earnings date and no analyst target. If you want a reason for the move, it isn't here.

Planet Labs launch plus insider selling

PL closed up 8.4% at $17.50 on 14.9 million shares against an 8.8 million average. The event behind it is the October 1 launch of 20 satellites on SpaceX's Transporter-18 rideshare from Vandenberg, Planet's 40th successful launch. The payload included Tanager-2, a hyperspectral imager, 18 SuperDoves, and a demonstration satellite for Google's Project Suncatcher, which is testing Google Tensor Processing Units in orbit with the aim of running machine learning computation in space. Set against that, the insider picture is one-sided: GuruFocus counts $52.6 million of insider sales over the past twelve months against zero purchases, 22 sells versus one buy, including Director Ita Brennan selling 11,500 shares on October 1 at roughly $16.30, leaving her with 250,373. GuruFocus puts its GF Value at $5.63 against the $17.50 price and flags a price-to-sales of 14.27 versus a 4.72 historical median, with the company unprofitable at a -95% net margin on $378 million trailing revenue. Yahoo shows a one-year analyst target of $33.40. One housekeeping point: the 8-K filed under the PL tag is Planet Green Holdings Corp, an unrelated company, not Planet Labs.

Bernstein initiation drives Forgent Power

FPS was up 8.1% on a Bernstein SocGen initiation at Outperform with a $48 target, against a prior close of $37.33, roughly 29% upside. Analyst Chad Dillard's case is that the stock trades at a discount to peers on three drivers: more content per megawatt as modular data center construction grows from 40% of the market to 60% by 2030, which lifts Forgent's content opportunity 55% to $2.8 million per megawatt as it moves from discrete components to integrated systems; share gains, where it already holds about 7% among non-hyperscalers versus 4% overall and has just landed a first hyperscaler win; and margin expansion of 500 basis points to a 28% EBITDA margin by 2030 on higher utilization and SG&A leverage. He models a 70% EPS CAGR through 2030 against a street figure near 60%. Roughly 80% of revenue comes from data centers and the grid, and lead times run 30% to 50% below industry average. The prior analyst stack is already bullish: TD Cowen at $76 Buy, KeyBanc Overweight at $60, Wells Fargo Equal Weight at $44, with backlog up 53% quarter over quarter on record orders and FY27 revenue guidance about 20% above consensus. The dissenting note is GuruFocus, which scores FPS 20/100 and flags a trailing P/E of 138.77x. The stock hit $40.28 intraday and remains well below its $66 52-week high; it IPO'd in February 2026.

SpaceX up 7% on launch flow

SPCX rose 7.4%, the second-largest move here, but the depth behind it is thin. The two Musk posts read in full say only that "SpaceX is a super intelligence company" and that Starship is deploying Starlink V3 satellites. Headline-only items attribute the move to key launches and elevated options activity, and others raise the Starlink residential broadband opportunity and the cost of 2027 profit expectations. Separately, three GuruFocus 13F pieces tagged to SPCX are actually about other names (Indivior, Amerisafe, Allogene); SPCX shows up in them only as a top holding of Millennium Management and TPG GP A.

NetApp and Rocket Lab

NTAP was up 5.2% to what one headline calls an all-time high, with Loop Capital raising its target to $260 and a separate headline on CEO George Kurian selling 50,000 shares. Another ties NetApp storage to Oracle and AI migration. RKLB rose 4.9%; the headlines cite a record 20-launch deal and a $16 million purchase by Cathie Wood's ARK, which also sold Palantir. These are headline-only, so that's the extent of what I can tell you.

Broadcom financing and Oracle insider buy

AVGO gained 3.3%, with a cluster of headlines on Broadcom lining up a $60 billion debt package to fund AI chips, reportedly for Anthropic per Bloomberg, alongside a reiterated UBS Buy. ORCL was up 3.1% with a director, Stephen Rusckowski, buying $3.48 million of stock, Citizens reiterating Outperform at $285, and Oracle subscribing to power from the Point Beach nuclear plant. TSM added 3.0%. All headline-only.

The decliners

Nothing on the downside moved much. SNDK was the weakest at -3.8%, with headlines on its chief legal officer selling about $1 million of stock. BBAI fell 3.3%, VEEA 4.0% on an 8-K covering a material agreement and a new financial obligation, and BYSI 3.2% on an 8-K about a Nasdaq continued-listing failure. NFLX slipped 1.2% alongside news that Disney licensed a slate of films and shows to it. ASTS was actually up 2.5% despite a B. Riley downgrade with the target cut to $65 on pricing concerns.

The long tail

The remainder of the list is quiet. AAPL closed up 1.0% with a long run of ETF-flow and privacy-feature headlines and an insider sale by Jennifer Newstead, and the rest, Costco, Teva, Marathon Petroleum, Aflac, Joby, Iovance, is routine filing and ETF-rebalance noise with sub-1% moves.